, The European Union (HEALTH-F7-305507 HOMAGE) and the European Research Council (Advanced Researcher grant 2011-294713-EPLORE and Proof-of-Concept grant 713601-uPROPHET) and the European Research Area Net for Cardiovascular Diseases (JTC2017-046-PROACT) supported research at the Studies Coordinating Centre, AON 10-216) and by the Societé Française d' Anesthésie-Réanimation
The French and European Outcome Registry in Intensive Care Unit Investigators Hôpital Lariboisière (Paris) ,
,
,
, Hôpital Beaujon (Clichy)-I Rennuit, C Paugam
,
,
,
,
,
,
,
,
,
,
Threeyear outcomes for Medicare beneficiaries who survive intensive care, J Am Med Assoc, vol.303, pp.849-56, 2010. ,
Intensive care unit admission has minimal impact on long-term mortality, Crit Care Med, vol.30, pp.501-508, 2002. ,
Determinants of long-term survival after intensive care, Crit Care Med, vol.36, pp.1523-1553, 2008. ,
A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010 : a systematic analysis for the Global Burden of Disease Study, Lancet, vol.380, pp.2224-60, 2010. ,
, Brussels Roundtable Participants: surviving intensive care: a report from the 2002 Brussels Roundtable, pp.368-77, 2002.
Long-term complications of critical care, Crit Care Med, vol.39, pp.371-380, 2011. ,
Improving long-term outcomes after discharge from intensive care unit: report from a stakeholders conference, Crit Care Med, vol.40, pp.502-511, 2012. ,
Determinants of long-term outcome in ICU survivors: results from the FROG-ICU study, Crit Care, vol.22, p.8, 2018. ,
URL : https://hal.archives-ouvertes.fr/hal-01791634
Technical aspects and inter-laboratory variability in native peptide profiling : the CE-MS experience, Clin Biochem, vol.46, pp.432-475, 2013. ,
Peptidomics and proteomics based on CE-MS as a robust tool in clinical application: the past, the present, and the bright future, Electrophoresis, vol.40, 2019. ,
Post-ICU discharge and outcome: rationale and methods of the The French and euRopean Outcome reGistry in Intensive Care Units (FROG-ICU) observational study, BMC Anesthesiol, vol.15, p.143, 2015. ,
URL : https://hal.archives-ouvertes.fr/hal-01768461
The Glasgow Coma Scale, J Emerg Med, vol.19, pp.67-71, 2000. ,
A method of classifying prognostic comorbidity in longitudinal studies: development and validation, J Chron Dis, vol.40, pp.373-83, 1987. ,
, Charlson Comorbidity Index. J Physiother, vol.32, p.171, 2016.
Serial evaluation of the SOFA score to predict outcome in critically ill patients, J Am Med Assoc, vol.286, pp.1754-1762, 2001. ,
Estimating glomerular filtration rate from serum creatinine and cystatin C, N Engl J Med, vol.367, pp.20-29, 2012. ,
Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population, JAMA, vol.304, pp.2503-2515, 2010. ,
High-sensitive troponin I in acute cardiac conditions: implications of baseline and sequential measurements for diagnosis of myocardial infarction, Atherosclerosis, vol.222, pp.116-138, 2012. ,
Circulating biologically active adrenomedullin (bio-ADM) predicts hemodynamic support requirement and mortality during sepsis, Chest, vol.152, pp.312-332, 2017. ,
Soluble ST2 in heart failure, Clin Chim Acta, vol.443, pp.57-70, 2015. ,
Neutrophil gelatinase-associated lipocalin (NGAL), Scand J Clin Lab Invest Suppl, vol.241, pp.89-94, 2008. ,
Comprehensive human urine standards for comparability and standardization in clinical proteome analysis, Proteomics Clin Appl, vol.4, pp.464-78, 2010. ,
Statistical estimates and transformed beta-variables, Biom J, vol.3, p.285, 1961. ,
Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers, Stat Med, vol.30, pp.11-21, 2011. ,
Proteasix : a tool for automated and large-scale prediction of proteases involved in naturally occurring peptide generation, Proteomics, vol.13, pp.1077-82, 2013. ,
The Proteasix ontology, J Biomed Semantics, vol.7, p.33, 2016. ,
Biomarker-guided intervention to prevent acute kidney injury after major surgery. The Prospective Randomized BigpAK Study, Ann Surg, vol.267, pp.1013-1033, 2018. ,
Plasma adrenomedullin in critically ill patients with sepsis after major surgery : a pilot study, J Crit Care, vol.38, pp.68-72, 2017. ,
Circulating adrenomedullin estimates survival and reversibility of organ failure in sepsis : the prospective observational multinational Adrenomedullin and Outcome in Sepsis and Septic Shoch-1 (AdrenOSS-1) Study, Crit Care, vol.22, p.354, 2019. ,
N-terminal pro-brain natriuretic peptide and high-sensitivity troponin T exhibit additive prognostic value for the outcome of critically ill patients, Eur Heart J Acute Cardiovasc Care, 2018. ,
Retrospective study on prognostic importance of serum procalcitonin and aminoterminal pro-brain natriuretic peptide levels as compared to Acute Physiology and Chronic Health Evaluation IV Score on intensive care unit admission in a mixed intensive care unit population, Ann Card Anaesth, vol.19, pp.256-62, 2016. ,
Proteolysis in septic shock patients: plasma peptidomic patterns are associated with mortality, Br J Anaesth, vol.121, pp.1065-74, 2018. ,
High-sensitive cardiac troponin T is superior to echocardiography in predicting 1-year mortality in patients with SIRS and shock in intensive care, BMC Anesthesiol, vol.12, p.25, 2012. ,
Troponin I as an early biomarker of cardiopulmonary parameters within the first 24 hours after nontraumatic subarachnoid hemorrhage in intensive care unit patients, J Intensive Care Med ,
Interleukin 6, galectin 3, growth differentiation factor 15, and soluble ST2 for mortality prediction in critically ill patients, J Crit Care, vol.34, pp.38-45, 2016. ,
Urinary versus plasma neutrophil gelatinase-associated lipocalin (NGAL) as a predictor of mortality for acute kidney injury in intensive care unit patients, J Clin Anesth, vol.44, pp.12-19, 2018. ,
Comparison of plasma and urine biomarker performance in acute kidney injury, PLoS One, vol.10, p.145042, 2015. ,
Endocytic delivery of lipocalin-siderophore-iron complex rescues the kidney from ischemia-reperfusion injury, J Clin Invest, vol.115, pp.610-631, 2005. ,
The endocytic receptor megalin binds the iron transporting neutrophilgelatinase-associated lipocalin with high affinity and mediates its cellular uptake, FEBS Lett, vol.579, pp.773-780, 2005. ,
Neutrophil gelatinase-associated lipocalin as a biomarker of acute kidney injury--where do we stand today?, Nephrol Dial Transplant, vol.26, pp.762-766, 2011. ,
Renal stress in vivo in real-time--visualised by the NGAL reporter mouse, Nephrol Dial Transplant, vol.26, pp.2109-2120, 2011. ,
Amino-terminal pro-brain natriuretic peptide as predictor of outcome in patients admitted to intensive care. A prospective observational study, Eur J Anaesthesiol, vol.29, pp.275-284, 2012. ,
Characterization of the human urinary proteome : a method for high-resolution display of urinary proteins on two-dimensional electrophoresis gels with a yield of nearly 1400 distinct protein spots, Proteomics, vol.4, pp.1159-74, 2004. ,
CE-MS analysis of the human urinary proteome for biomarker discovery and disease diagnostics, Proteomics Clin Appl, vol.2, pp.964-73, 2008. ,
Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease, Mol Cell Proteomics, vol.9, pp.2424-2461, 2010. ,
Urinary proteomic diagnosis of coronary artery disease: identification and clinical validation in 623 individuals, J Hypertens, vol.28, pp.2316-2338, 2010. ,
The urinary proteome as correlate and predictor of renal function in a population study, Nephrol Dial Transplant, vol.29, pp.2260-2268, 2014. ,
Prediction of chronic kidney disease stage 3 by CKD273, a urinary proteomic biomarker, KI Reports, vol.2, pp.1066-75, 2017. ,
Urinary proteome analysis in hypertensive patients with left ventricular diastolic dysfunction, Eur Heart J, vol.33, pp.2342-50, 2012. ,
Epidemiologic observations guiding clinical application of the HF1 urinary peptidomic marker of diastolic left ventricular dysfunction, J Am Soc Hypertens, vol.12, pp.438-485, 2018. ,
Cost-effectiveness of screening type 2 diabetes patients for chronic kidney disease progression with the CKD273 urinary peptide classifier as compared to urinary albumin excretion, Nephrol Dial Transplant, vol.33, pp.441-450, 2018. ,
Proteomic prediction and renin angiotensin aldosterone system inhibition prevention of early diabetic nephropathy in type 2 diabetic patients with normoalbuminuria (PRIORITY) : essential study design and rationale of a randomised clinical multicentre trial, Br Med J Open, p.10310, 2016. ,
Characteristics of high-and low-risk individuals in the PRIORITY study: urinary proteomics and mineralocorticoid receptor antagonism for prevention of diabetic nephropathy in type 2 diabetes, Diabet Med, vol.35, pp.1375-82, 2018. ,
What is measured by cardiac fibrosis biomarkers and imaging? Circ Heart Fail, vol.7, pp.239-281, 2014. ,
The use of novel nonsteroidal mineralocorticoid receptor antagonist finerenone for the treatment of chronic heart failure. A systematic review and meta-analysis, Medicine (Baltimore), vol.97, p.254, 2018. ,
Sacubitril/valsartan decreases cardiac fibrosis in left ventricle pressure overload by restoring PKG signaling in cardiac fibroblasts, Circ Heart Fail, vol.12, 2019. ,
, Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations